EGFR and non-small cell lung carcinoma: In addition, we found that patients with EGFR mutations had significantly lower median TMB compared with those with wild‐type EGFR, consistent with another study in which the TMB value of EGFR‐mutant nonsquamous NSCLC was half that of wild‐type.37